InvestorsHub Logo
Followers 58
Posts 10138
Boards Moderated 1
Alias Born 09/21/2016

Re: kevindenver post# 408441

Saturday, 03/25/2023 9:02:48 AM

Saturday, March 25, 2023 9:02:48 AM

Post# of 461943
I hear this guy saying that the FDA "silver bullet" Amyloid plaque thesis is finally dead (note many recent FDA fails) and that CNS diseases (like AD) will use AVXL ("00 Buckshot-mixed loads).

"The changing therapeutic landscape" and "There are really interesting small molecules directed at disease modification"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News